Blog | Medical and Pharma I

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

Jun 19
3 min

RK Pharma wraps up acquisition of developer of clinical critical therapies VGYAAN Pharmaceuticals

RK Pharma focuses on the development, manufacturing, and sale of high quality and affordable generic pharmaceutical products worldwide.

Jun 13
4 min

HanAll Biopharma and Daewoong Pharmaceutical invest in Vincere Biosciences for Parkinson's Research

This partnership highlights the joining of forces across a shared mission to deliver disease-modifying medicines for Parkinson's disease.

Jun 7
8 min

CERo Therapeutics to merge with SPAC and advance engineered T Cell therapeutics

Phoenix Biotech Acquisition Corp. (NASDAQ: PBAX) is a blank-check company formed for the purpose of effecting a merger, share exchange...

Jun 2
5 min

Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure

Alleviant’s mission is to bring a safe, effective no-implant treatment option to millions of patients suffering from heart failure.

May 26
4 min

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons

. NurrOn is focused on the discovering and developing novel therapies for people with neurodegenerative diseases including Parkinson's...

May 22
6 min

Startups Wanted: Catalyst by Wellstar Launches $100 Million Fund to Shape Future of Healthcare

Wellstar will directly influence the problems addressed and solutions created by the nation's most promising startups and entrepreneurs.

May 19
3 min

Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

May 18
6 min

HealthSnap closes $9 Million for its remote patient monitoring and chronic care management platform

HealthSnap is an integrated virtual care management platform that helps healthcare organizations improve patient outcomes...

May 15
2 min

Sealonix raises $20 Million to develop sealants for abdominopelvic and orthopedic procedures

The PramStat patch builds on many years of research done by this experienced team, and now will move rapidly into clinical development.

May 12
6 min

Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction

Regentis’ current efforts are focused on orthopedic treatments using its Gelrin platform based on resorbable hydrogel implants to regenerate

May 11
3 min

Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology

DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.

May 6
6 min

MultiOmic Health Closes $6.2 Million for precision medicines for metabolic syndrome conditions

The proceeds of this financing will be used to demonstrate proof-of-concept for MultiOmic’s MOHSAIC platform in diabetic kidney disease

May 5
3 min

Galmed Pharmaceuticals and OnKai partner for clinical studies in underserved communities

Through this partnership, the companies intend to facilitate faster clinical trial enrollment and provide patients with access to medicines

May 4
4 min

Magenta Medical raises $55 million to advance the world's smallest heart pump

Magenta's Elevate™ percutaneous left ventricular assist device is currently in clinical testing

May 3
4 min

Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials

We significantly grew our clinical trial programs for central nervous system cancers in 2022 and we expect to continue this momentum

Apr 27
4 min

Mezzion Pharma raises $40 million for its first-to-market treatment for fontan patients

The average life expectancy for a Fontan patient is 35-45 and apart from JURVIGO, there are currently no other pharmacotherapies available

Apr 25
2 min

ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP

ANI Pharmaceuticals (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing,

Apr 24
4 min

Artificial intelligence Digital Diagnostics now available at nine Labcorp centers

Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform global health care.

Apr 21
3 min

Gale Healthcare partners with Smartlinx to address America's nursing shortage

Gale has one of the fastest growing networks of supplemental clinicians in the country and serves thousands of healthcare clients...

Apr 20
3 min

Singapore-based Ross Swan joins FC Global Strategies as Managing Director, Asia-Pacific

Medical and Pharma Insider is a program of FC Global Strategies.

Apr 19
2 min

Medical device company, BioVentrix closes on $48.5 million to improve cardiac function

BioVentrix is a medical device company focused on the development of less invasive therapies to treat the failing left ventricle.

Apr 18
4 min

Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases

Aer Therapeutics is a clinical stage biopharmaceutical company with a mission to develop novel treatments for mucus-associated lung diseases

Apr 17
3 min

Professional Health Care Network rebrands as "Tango" and expands its strategic partnerships

Tango's services provide higher quality care, improved access, better patient outcomes, and reduced total costs...

Apr 14
4 min

Novo Holdings participates in $105 million funding in Alentis Therapeutics

Alentis Therapeutics is a biotechnology company that focuses on developing treatments for CLDN1+ tumors and organ fibrosis.